Ryan S Cross (Ryan Cross)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Mesenchymal Stem Cells

Ejection Fraction

Top Venues

Clinical & translational immunology

Journal for immunotherapy of cancer

Neuro-oncology advances

This page only lists publications with an associated author ORCID identifier.

Publications

Leesa Lertsumitkul, Melinda Iliopoulos, Stacie S Wang, Sarah J McArthur, Lisa M Ebert, Alexander J Davenport, Raelene Endersby, Jordan R Hansford, Katharine J Drummond, Ryan S Cross, Misty R Jenkins
EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses. Journal for immunotherapy of cancer 12 (8) (2024)
Leesa Lertsumitkul, Melinda Iliopoulos, Stacie S Wang, Sarah J McArthur, Lisa M Ebert, Alexander J Davenport, Raelene Endersby, Jordan R Hansford, Katharine J Drummond, Ryan S Cross, Misty R Jenkins
EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses. Journal for immunotherapy of cancer 12 (8) (2024)
Leesa Lertsumitkul, Melinda Iliopoulos, Stacie S Wang, Sarah J McArthur, Lisa M Ebert, Alexander J Davenport, Raelene Endersby, Jordan R Hansford, Katharine J Drummond, Ryan S Cross, Misty R Jenkins
EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses. Journal for immunotherapy of cancer 12 (8) (2024)
Rebecca C Abbott, Melinda Iliopoulos, Katherine A Watson, Valeria Arcucci, Margareta Go, Hannah E Hughes-Parry, Pete Smith, Melissa J Call, Ryan S Cross, Misty R Jenkins
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma. Clinical & translational immunology 12 (3) (2023)
Rebecca C Abbott, Melinda Iliopoulos, Katherine A Watson, Valeria Arcucci, Margareta Go, Hannah E Hughes-Parry, Pete Smith, Melissa J Call, Ryan S Cross, Misty R Jenkins
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma. Clinical & translational immunology 12 (3) (2023)
Stacie S Wang, Alexander J Davenport, Melinda Iliopoulos, Hannah E Hughes-Parry, Katherine A Watson, Valeria Arcucci, Matthias Mulazzani, David D Eisenstat, Jordan R Hansford, Ryan S Cross, Misty R Jenkins
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma. Neuro-oncology advances 5 (1) (2023)
Stacie S Wang, Alexander J Davenport, Melinda Iliopoulos, Hannah E Hughes-Parry, Katherine A Watson, Valeria Arcucci, Matthias Mulazzani, David D Eisenstat, Jordan R Hansford, Ryan S Cross, Misty R Jenkins
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma. Neuro-oncology advances 5 (1) (2023)
Rebecca C Abbott, Daniel J Verdon, Fiona M Gracey, Hannah E Hughes-Parry, Melinda Iliopoulos, Katherine A Watson, Matthias Mulazzani, Kylie Luong, Colleen D'Arcy, Lucy C Sullivan, Ben R Kiefel, Ryan S Cross, Misty R Jenkins
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma. Clinical & translational immunology 10 (5) (2021)